Literature DB >> 17850340

Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.

R Saito1, S Okugawa, W Kumita, K Sato, T Chida, N Okamura, K Moriya, K Koike.   

Abstract

This study investigated the clinical characteristics of ciprofloxacin-resistant Proteus mirabilis isolates from urine samples associated with nosocomial infection or colonisation, and identified the risk-factors for ciprofloxacin resistance. Data for patients with ciprofloxacin-resistant P. mirabilis isolates (n=13) were compared with those for randomly selected patients with ciprofloxacin-susceptible P. mirabilis isolates (n=40) who were matched by temporal occurrence as control patients. The majority of ciprofloxacin-resistant P. mirabilis isolates were multiresistant, and ciprofloxacin resistance was associated significantly with previous use of fluoroquinolones and production of extended-spectrum beta-lactamases.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17850340     DOI： 10.1111/j.1469-0691.2007.01826.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


  6 in total

1.  Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes.

Authors:  K Cohen-Nahum; L Saidel-Odes; K Riesenberg; F Schlaeffer; A Borer
Journal:  Infection       Date:  2009-12-07       Impact factor: 3.553

2.  Ciprofloxacin-resistant Gram-negative isolates from a tertiary care hospital in Eastern India with novel gyrA and parC gene mutations.

Authors:  Ashoka Mahapatra; A Raj Kumar Patro; Atul Khajuria; Sagarika Dhal; Ashok Kumar Praharaj
Journal:  Med J Armed Forces India       Date:  2020-01-08

3.  The assessment of Proteus mirabilis susceptibility to ceftazidime and ciprofloxacin and the impact of these antibiotics at subinhibitory concentrations on Proteus mirabilis biofilms.

Authors:  Joanna Kwiecińska-Piróg; Krzysztof Skowron; Katarzyna Zniszczol; Eugenia Gospodarek
Journal:  Biomed Res Int       Date:  2013-09-12       Impact factor: 3.411

4.  Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Proteus mirabilis bacteremia.

Authors:  Kyung Mok Sohn; Cheol-In Kang; Eun-Jeong Joo; Young Eun Ha; Doo Ryeon Chung; Kyong Ran Peck; Nam Yong Lee; Jae-Hoon Song
Journal:  Korean J Intern Med       Date:  2011-03-03       Impact factor: 2.884

5.  The Ciprofloxacin Impact on Biofilm Formation by Proteus Mirabilis and P. Vulgaris Strains.

Authors:  Joanna Kwiecinska-Pirog; Krzysztof Skowron; Wojciech Bartczak; Eugenia Gospodarek-Komkowska
Journal:  Jundishapur J Microbiol       Date:  2016-04-23       Impact factor: 0.747

6.  In vitro anti-biofilm activity of bacteriocin from a marine Bacillus sp. strain Sh10 against Proteus mirabilis.

Authors:  Fatemeh Shayesteh; Asmat Ahmad; Gires Usup
Journal:  Iran J Microbiol       Date:  2020-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.